申请人:Hoffmann-La Roche Inc.
公开号:US20140336208A1
公开(公告)日:2014-11-13
This invention relates to compounds of the formula
wherein R
1
to R
9
are as described below, or to pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the therapeutic and/or prophylactic treatment of diseases such as diabetes, particularly type 2 diabetes, and other metabolic disorders.
本发明涉及以下式子中的化合物,其中R1至R9如下所述,或其药学上可接受的盐。这些化合物是BACE2抑制剂,可用作药物治疗和/或预防糖尿病等疾病,特别是2型糖尿病和其他代谢性疾病的治疗剂。